SCHEMBL7306710

SCHEMBL7306710

N[C@@H](Cc1ccccc1)[C@@H]1O[C@@H]1[C@@H](N)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.54
SLC6A2 P23975 2/20 0.50
TAAR1 Q96RJ0 2/20 0.50
MAOA P21397 1/20 0.50
SLC6A4 P31645 1/20 0.50
SLC6A3 Q01959 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
CYP2A6 P11509 1/20 0.50
ADORA2A P29274 1/20 0.50
ADORA1 P30542 1/20 0.50
ANPEP P15144 3/20 0.47
CYP2D6 P10635 1/20 0.47
ALPI P09923 1/20 0.45
PKM P14618 1/20 0.45
PTGS1 P23219 1/20 0.45
XIAP P98170 1/20 0.45
SLC7A5 Q01650 1/20 0.45
LAP3 P28838 4/20 0.42
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7301303 0.98 EPHX1 (0.52) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL8660233 0.84 EPHX1 (0.42) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL8945893 0.79 LAP3 (0.47) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL8014276 0.79 EPHX1 (0.45) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL8531796 0.79 LAP3 (0.47) EPHX1SLC6A2TAAR1MAOASLC6A4
Hydrochloric Acid SCHEMBL7303614 0.78 ANPEP (0.44) EPHX1SLC6A2TAAR1MAOASLC6A4
SCHEMBL7298579 0.77 HTR2A (0.59) EPHX1SIGMAR1CYP2A6SLC1A3SLC1A2
SCHEMBL13660788 0.76 CYP2D6 (0.50) EPHX1SLC6A2TAAR1MAOASLC6A4
Hydrochloric Acid SCHEMBL7299669 0.76 HTR2A (0.57) EPHX1MAOASIGMAR1CYP2A6SLC1A3
SCHEMBL6562522 0.75 EPHX1 (0.50) EPHX1SLC6A2TAAR1MAOASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0652009-A1 Identification and use of protease inhibitors ELI LILLY AND COMPANY (US) 1995-05-10 EP disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed